Please use this identifier to cite or link to this item:
Title: Erratum. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide in Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin: The LixiLan-L Randomized Trial. Diabetes Care 2016;39:1972-1980.
Authors: Aroda, Vanita R;Rosenstock, Julio;Wysham, Carol;Unger, Jeffrey;Bellido, Diego;Gonzalez-Galvez, Guillermo;Takami, Akane;Guo, Hailing;Niemoeller, Elisabeth;Souhami, Elisabeth;Bergenstal, Richard M;Investigators, LixiLan-L Trial
subject: Medical Science
Year: 2017
volume: Volume 40
issue: Issue 6
month: June
Appears in Collections:Diabetes Care 2017

Files in This Item:
File Description SizeFormat 
DiabetCare 2017 Volume 40 Issue 6 June (17).pdf435.37 kBAdobe PDFThumbnail
Download    Request a copy

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.